Study of a blood filter for sudden liver failure
Part of Brain & nervous system, Digestive system clinical trials.
This trial tests a device called CytoSorb that filters the blood to reduce inflammation in patients with sudden worsening of chronic liver disease. It may help support organ function and recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and admitted to University Hospital Antwerp.
- You have sudden liver failure (ACLF) with confusion, kidney injury, jaundice, and needing medicine to keep blood pressure up.
- You have a known trigger for the liver worsening, like an infection or bleeding.
- You or your family can give permission for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This registry collects information about critically ill patients who receive the CytoSorb 300 mL blood treatment. It may help doctors better understand when the treatment works best and when it should not be used.
This trial tests whether infusing stem cells (from a healthy donor) can help people with sudden liver failure that is not getting better with standard medicines and is not caused by viruses. It aims to improve liver function and possibly avoid the need for a transplant.
This study tests a blood-filtering system called CytoSorb in people with severe liver failure that also affects other organs. It aims to see if removing toxins from the blood can help reduce damage and improve recovery.
This trial tests a procedure that filters harmful substances from your blood using a special machine. It is for people with severe liver failure (acute-on-chronic) who have signs of inflammation throughout the body.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
Hear when a new Acute-On-Chronic Liver Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.